
    
      The objectives of this study are to evaluate the therapeutic equivalence and safety of the
      test product Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to the reference product
      Onextonâ„¢ Gel (Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75%) in the treatment of acne
      vulgaris and to demonstrate the superiority of the efficacy of these test and reference
      products over the placebo control.
    
  